Postoperative tamoxifen for ductal carcinoma in situ - Wikidata - awgldk - TriplyDB

Postoperative tamoxifen for ductal carcinoma in situ

Postoperative tamoxifen for ductal carcinoma in situ

http://www.wikidata.org/entity/Q24198028

about

AGO Recommendations for Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2013.Primary chemoprevention of breast cancer: Are the adverse effects too burdensome?Long-term outcomes of ductal carcinoma in situ of the breast: a systematic review, meta-analysis and meta-regression analysis.DNA methylation in ductal carcinoma in situ of the breast.Breast Ductal Carcinoma In Situ: A Literature Review of Adjuvant Hormonal Therapy.Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004-2013.Paradigm Shift toward Reducing Overtreatment of Ductal Carcinoma In Situ of Breast.Prescribing practices of endocrine therapy for ductal carcinoma in situ in British Columbia.

P2860

Q30317579-9F6F38BA-6B3B-41AD-A485-F65DA1743E6B Q35744037-91F9AA7A-37B1-4D84-B007-4212B9F850F3 Q35837432-174F0042-783E-490D-BCAD-52395781F46C Q36998647-C4FDDBD0-ED90-4668-A867-6B8C813FC98A Q37527260-EBC04491-FBBF-4F5C-8EF2-BEFB0BCBBE82 Q38641730-D2215380-58EB-41E8-874F-47609A960280 Q47097148-6908839E-FBD4-4751-B220-5D7E20AD69BF Q55359783-88DFD960-F27E-40B7-AFB9-5A99339F9BA3

P2860

Postoperative tamoxifen for ductal carcinoma in situ

http://www.wikidata.org/entity/Q24198028

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Postoperative tamoxifen for ductal carcinoma in situ

@ast

Postoperative tamoxifen for ductal carcinoma in situ

@en

Postoperative tamoxifen for ductal carcinoma in situ

@en-gb

Postoperative tamoxifen for ductal carcinoma in situ

@nl

type

label

Postoperative tamoxifen for ductal carcinoma in situ

@ast

Postoperative tamoxifen for ductal carcinoma in situ

@en

Postoperative tamoxifen for ductal carcinoma in situ

@en-gb

Postoperative tamoxifen for ductal carcinoma in situ

@nl

prefLabel

Postoperative tamoxifen for ductal carcinoma in situ

@ast

Postoperative tamoxifen for ductal carcinoma in situ

@en

Postoperative tamoxifen for ductal carcinoma in situ

@en-gb

Postoperative tamoxifen for ductal carcinoma in situ

@nl

P1433

Q24198028-FEBFE35A-388B-4D10-9C25-98EC215CD681

P1476

Q24198028-B45C36D0-9D82-4647-997E-E5772950E083

P2093

Q24198028-1554FA3D-F8F4-4C4C-BF38-53A816492809

Q24198028-7E9920E1-309A-479C-8091-599650AA4AA1

Q24198028-C9020DE5-23AE-4F36-A8ED-A7F194452621

P2860

Q24198028-1709F139-F420-436A-8248-8979135509BE

Q24198028-21176F6B-45C9-44A5-84FC-CDBCF25A3D7B

Q24198028-2C157E22-B117-45BE-AB50-92C3F7B05E51

Q24198028-2E8FF7AC-24D0-4081-B074-4E881C4A4633

Q24198028-3AA9CC58-33EC-47AD-A783-E96263D04529

Q24198028-44CA0210-74B0-41FF-8D8A-E142FB9E1916

Q24198028-54497E3C-B9D6-4A79-92E6-98AD0CEEDBDE

Q24198028-57E8B053-7CA9-4D49-BEE1-DE0735792DF5

Q24198028-59B5F668-2933-4C6B-9765-971E054C56A3

Q24198028-765BC6BF-AAFE-4B77-B932-9ADBEDF86F12

P31

Q24198028-DBDD54B8-BB0C-4BE4-9794-3F4AE716F01C

Q24198028-d3bccc8a-5d3f-41c8-862e-befa282b70b3

P356

Q24198028-5F6ABA22-266F-4FED-A1D4-91D6F7897A0E

P577

Q24198028-9B8AF378-A558-402A-9D99-C1C63E99F725

P698

Q24198028-E15A4EAF-2F7E-4013-B735-DFE5B9F10DDD

P921

Q24198028-E66B5BDD-A4CD-422C-B27D-571748B0C31F

P356

14651858.CD007847.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Postoperative tamoxifen for ductal carcinoma in situ

@en

P2093

Helen Staley

http://www.w3.org/2001/XMLSchema#string

Iain McCallum

http://www.w3.org/2001/XMLSchema#string

Julie Bruce

http://www.w3.org/2001/XMLSchema#string

P2860

Postoperative tamoxifen for ductal carcinoma in situ

Practical methods for incorporating summary time-to-event data into meta-analysis

Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial

Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ

Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women.

Tamoxifen for early breast cancer.

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

Radiotherapy for ductal carcinoma in situ detected by screening.

P31

scholarly article

P356

10.1002/14651858.CD007847.PUB2

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23076938

http://www.w3.org/2001/XMLSchema#string

P921